Veradermics Inc stock is traded at $128.60, with a volume of 788,035. It is down -5.79% in the last 24 hours and up +8.19% over the past month. Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.
Previous Close:
$136.51
Open:
$136.20
24h Volume:
788,035
Relative Volume:
1.52
Market Cap:
$5.37B
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-$0.94
Net Cash Flow:
-
1W Performance:
-10.60%
1M Performance:
+8.19%
6M Performance:
+12.02%
1Y Performance:
0.00%
1-Day Range:
$125.34$136.50
1-Week Range:
$125.34$139.72
52-Week Range:
$32.00$146.58
Veradermics Inc Stock (MANE) Company Profile
Name
Veradermics IncSector
HealthcareIndustry
BiotechnologyPhone
228.372.3376Address
470 JAMES STREET, NEW HAVEN, USAMarket Cap
Revenue
Net Income
Cash Flow
EPS